{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:59:56Z","timestamp":1790197196997,"version":"4.1.0"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.phrs.2017.11.008","type":"journal-article","created":{"date-parts":[[2017,11,10]],"date-time":"2017-11-10T15:47:29Z","timestamp":1510328849000},"page":"308-317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Myocardial infarction and gut microbiota: An incidental connection"],"prefix":"10.1016","volume":"129","author":[{"given":"Sepideh","family":"Zununi Vahed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abolfazl","family":"Barzegari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisol","family":"Zuluaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Letourneur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graciela","family":"Pavon-Djavid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.phrs.2017.11.008_bib0005","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1056\/NEJMcibr1604458","article-title":"A gut feeling about thrombosis","volume":"374","author":"Tilg","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.phrs.2017.11.008_bib0010","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3945\/ajcn.2009.27725","article-title":"Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease","volume":"91","author":"Siri-Tarino","year":"2010","journal-title":"Am. J. Clin. Nutr."},{"issue":"7","key":"10.1016\/j.phrs.2017.11.008_bib0015","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/CIRCRESAHA.117.309715","article-title":"Gut microbiota in cardiovascular health and disease","volume":"120","author":"Tang","year":"2017","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.phrs.2017.11.008_bib0020","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1161\/CIRCGENETICS.114.000219","article-title":"Does our gut microbiome predict cardiovascular risk? A review of the evidence from metabolomics","volume":"8","author":"Griffin","year":"2015","journal-title":"Circ. Cardiovasc. Genet."},{"issue":"2 Suppl 1","key":"10.1016\/j.phrs.2017.11.008_bib0025","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.1016\/j.dsx.2016.01.024","article-title":"Gut microbiome and metabolic syndrome","volume":"10","author":"Mazidi","year":"2016","journal-title":"Diabetes Metab. Syndr."},{"issue":"11","key":"10.1016\/j.phrs.2017.11.008_bib0030","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1007\/s11886-014-0540-1","article-title":"Far from the eyes, close to the heart: dysbiosis of gut microbiota and cardiovascular consequences","volume":"16","author":"Serino","year":"2014","journal-title":"Curr. Cardiol. Rep."},{"issue":"3","key":"10.1016\/j.phrs.2017.11.008_bib0035","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrneph.2015.191","article-title":"The gut microbiome, diet, and links to cardiometabolic and chronic disorders","volume":"12","author":"Aron-Wisnewsky","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.phrs.2017.11.008_bib0040","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.biopha.2017.02.114","article-title":"Gut microbiota and renal transplant outcome","volume":"90","author":"Ardalan","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phrs.2017.11.008_bib0045","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.biopha.2017.06.066","article-title":"The impact of gut microbiota on kidney function and pathogenesis","volume":"93","author":"Mahmoodpoor","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.phrs.2017.11.008_bib0050","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2217\/fca-2017-0014","article-title":"The gut microbiome and cardiovascular risk: current perspective and gaps of knowledge","volume":"13","author":"Talmor-Barkan","year":"2017","journal-title":"Future Cardiol."},{"issue":"10","key":"10.1016\/j.phrs.2017.11.008_bib0055","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1172\/JCI72331","article-title":"The contributory role of gut microbiota in cardiovascular disease","volume":"124","author":"Tang","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2017.11.008_bib0060","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.trsl.2016.07.007","article-title":"Microbiome, trimethylamine N-oxide, and cardiometabolic disease","volume":"179","author":"Tang","year":"2017","journal-title":"Transl. Res."},{"issue":"17","key":"10.1016\/j.phrs.2017.11.008_bib0065","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","article-title":"Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk","volume":"368","author":"Tang","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.phrs.2017.11.008_bib0070","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.carpath.2013.01.003","article-title":"Vascular fibrosis in atherosclerosis","volume":"22","author":"Lan","year":"2013","journal-title":"Cardiovasc. Pathol."},{"key":"10.1016\/j.phrs.2017.11.008_bib0075","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.pathol.1.110304.100100","article-title":"Inflammation and atherosclerosis","volume":"1","author":"Hansson","year":"2006","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"10.1016\/j.phrs.2017.11.008_bib0080","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1146\/annurev-med-060513-093205","article-title":"The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases","volume":"66","author":"Brown","year":"2015","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.phrs.2017.11.008_bib0085","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4137\/CMC.S33164","article-title":"Inflammation and inflammatory cells in myocardial infarction and reperfusion injury: a double-Edged sword","volume":"10","author":"Liu","year":"2016","journal-title":"Clin. Med. Insights Cardiol."},{"issue":"2","key":"10.1016\/j.phrs.2017.11.008_bib0090","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11897-016-0285-9","article-title":"Exploring the microbiome in heart failure","volume":"13","author":"Kitai","year":"2016","journal-title":"Curr. Heart Fail. Rep."},{"issue":"4","key":"10.1016\/j.phrs.2017.11.008_bib0095","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11936-017-0528-4","article-title":"Targeting the microbiome in heart failure","volume":"19","author":"Zabell","year":"2017","journal-title":"Curr. Treat Opt. Cardiovasc Med."},{"issue":"1","key":"10.1016\/j.phrs.2017.11.008_bib0100","first-page":"e11","article-title":"Intraplaque hemorrhage: a potential consequence of periodontal bacteria gathering in human carotid atherothrombosis","volume":"53","author":"Brun","year":"2016","journal-title":"Bull. Group. Int. Rech. Sci. Stomatol. Odontol."},{"issue":"8","key":"10.1016\/j.phrs.2017.11.008_bib0105","doi-asserted-by":"crossref","first-page":"e0160840","DOI":"10.1371\/journal.pone.0160840","article-title":"Intestinal microbial metabolites are linked to severity of myocardial infarction in rats","volume":"11","author":"Lam","year":"2016","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.phrs.2017.11.008_bib0110","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1161\/CIRCULATIONAHA.116.024251","article-title":"The gut microbiome and its role in cardiovascular diseases","volume":"135","author":"Tang","year":"2017","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.phrs.2017.11.008_bib0115","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1055\/s-0036-1597903","article-title":"The Intriguing link between the intestinal microbiota and cardiovascular disease","volume":"43","author":"Lippi","year":"2017","journal-title":"Semin. Thromb. Hemost."},{"issue":"12","key":"10.1016\/j.phrs.2017.11.008_bib0120","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s11886-015-0671-z","article-title":"Impact of gut microbiota on obesity, diabetes, and cardiovascular disease risk","volume":"17","author":"Miele","year":"2015","journal-title":"Curr. Cardiol. Rep."},{"issue":"7341","key":"10.1016\/j.phrs.2017.11.008_bib0125","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature09922","article-title":"Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease","volume":"472","author":"Wang","year":"2011","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.phrs.2017.11.008_bib0130","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jchf.2015.10.009","article-title":"Pathogenic gut flora in patients with chronic heart failure","volume":"4","author":"Pasini","year":"2016","journal-title":"JACC Heart Fail"},{"issue":"2","key":"10.1016\/j.phrs.2017.11.008_bib0135","doi-asserted-by":"crossref","first-page":"R51","DOI":"10.1530\/JME-13-0079","article-title":"Metabolic endotoxemia: a molecular link between obesity and cardiovascular risk","volume":"51","author":"Neves","year":"2013","journal-title":"J. Mol. Endocrinol."},{"issue":"11","key":"10.1016\/j.phrs.2017.11.008_bib0140","first-page":"814","article-title":"Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors","volume":"38","author":"Li","year":"2017","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.phrs.2017.11.008_bib0145","doi-asserted-by":"crossref","first-page":"e002314","DOI":"10.1161\/CIRCHEARTFAILURE.115.002314","article-title":"Choline diet and its gut microbe-derived metabolite, trimethylamine N-Oxide, exacerbate pressure overload-Induced heart failure","volume":"9","author":"Organ","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.phrs.2017.11.008_bib0150","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev-nutr-071816-064732","article-title":"Trimethylamine N-Oxide, the microbiome, and heart and kidney disease","volume":"37","author":"Zeisel","year":"2017","journal-title":"Annu. Rev. Nutr."},{"issue":"2","key":"10.1016\/j.phrs.2017.11.008_bib0155","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.atherosclerosis.2013.10.013","article-title":"Gut microbiota metabolism of L-carnitine and cardiovascular risk","volume":"231","author":"Ussher","year":"2013","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.phrs.2017.11.008_bib0160","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/MOL.0000000000000036","article-title":"Metaorganismal nutrient metabolism as a basis of cardiovascular disease","volume":"25","author":"Brown","year":"2014","journal-title":"Curr. Opin. Lipidol."},{"issue":"18","key":"10.1016\/j.phrs.2017.11.008_bib0165","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.jacc.2014.04.088","article-title":"Gut feelings about heart failure","volume":"64","author":"Cannon","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.phrs.2017.11.008_bib0170","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nm.3145","article-title":"Intestinal microbiota metabolism of L-carnitine: a nutrient in red meat, promotes atherosclerosis","volume":"19","author":"Koeth","year":"2013","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.phrs.2017.11.008_bib0175","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.metabol.2015.01.007","article-title":"New aspects on the metabolic role of intestinal microbiota in the development of atherosclerosis","volume":"64","author":"Drosos","year":"2015","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.phrs.2017.11.008_bib0180","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cell.2016.02.011","article-title":"Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk","volume":"165","author":"Zhu","year":"2016","journal-title":"Cell"},{"issue":"17","key":"10.1016\/j.phrs.2017.11.008_bib0185","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/CIRCULATIONAHA.116.025338","article-title":"Gut microbe-Generated trimethylamine N-Oxide from dietary choline is prothrombotic in subjects","volume":"135","author":"Zhu","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.11.008_bib0190","doi-asserted-by":"crossref","first-page":"26745","DOI":"10.1038\/srep26745","article-title":"Relationship of serum trimethylamine N-Oxide (TMAO) levels with early atherosclerosis in humans","volume":"6","author":"Randrianarisoa","year":"2016","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.phrs.2017.11.008_bib0195","doi-asserted-by":"crossref","first-page":"416","DOI":"10.26444\/aaem\/75456","article-title":"Gut microbiome as a biomarker of cardiometabolic disorders","volume":"24","author":"Gozd-Barszczewska","year":"2017","journal-title":"Ann. Agric. Environ. Med."},{"issue":"1","key":"10.1016\/j.phrs.2017.11.008_bib0200","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41467-017-00900-1","article-title":"The gut microbiome in atherosclerotic cardiovascular disease","volume":"8","author":"Jie","year":"2017","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.phrs.2017.11.008_bib0205","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.cell.2015.11.055","article-title":"Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis","volume":"163","author":"Wang","year":"2015","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.phrs.2017.11.008_bib0210","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1096\/fj.11-197921","article-title":"Intestinal microbiota determine severity of myocardial infarction in rats","volume":"26","author":"Lam","year":"2012","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.phrs.2017.11.008_bib0215","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1161\/CIRCHEARTFAILURE.113.000978","article-title":"Probiotic administration attenuates myocardial hypertrophy and heart failure after myocardial infarction in the rat","volume":"7","author":"Gan","year":"2014","journal-title":"Circ Heart Fail"},{"issue":"11","key":"10.1016\/j.phrs.2017.11.008_bib0220","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1096\/fj.12-1102LTR","article-title":"Intestinal microbiota determine severity of myocardial infarction in rats","volume":"26","author":"McCafferty","year":"2012","journal-title":"FASEB J."},{"issue":"10","key":"10.1016\/j.phrs.2017.11.008_bib0225","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1017\/S0007114509990766","article-title":"Lactobacillus helveticus and bifidobacterium longum taken in combination reduce the apoptosis propensity in the limbic system after myocardial infarction in a rat model","volume":"102","author":"Girard","year":"2009","journal-title":"Br. J. Nutr."},{"issue":"2","key":"10.1016\/j.phrs.2017.11.008_bib0230","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1079\/NRR200484","article-title":"The effects of probiotics on colon cancer development","volume":"17","author":"Rafter","year":"2004","journal-title":"Nutr. Res. Rev."},{"issue":"4","key":"10.1016\/j.phrs.2017.11.008_bib0235","doi-asserted-by":"crossref","first-page":"277","DOI":"10.7150\/ijms.14769","article-title":"Multi-strain probiotics inhibit cardiac myopathies and autophagy to prevent heart injury in high-fat diet-fed rats","volume":"13","author":"Lai","year":"2016","journal-title":"Int. J. Med. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2017.11.008_bib0240","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/01.RES.0000199348.10580.1d","article-title":"Cardiac myocyte apoptosis is associated with increased DNA damage and decreased survival in murine models of obesity","volume":"98","author":"Barouch","year":"2006","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.phrs.2017.11.008_bib0245","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1365-2796.2010.02270.x","article-title":"Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism","volume":"268","author":"Caesar","year":"2010","journal-title":"J. Intern. Med."},{"issue":"11","key":"10.1016\/j.phrs.2017.11.008_bib0250","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.numecd.2011.04.008","article-title":"Influence of consumption of probiotics on the plasma lipid profile: a meta-analysis of randomised controlled trials","volume":"21","author":"Guo","year":"2011","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"11","key":"10.1016\/j.phrs.2017.11.008_bib0255","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1139\/cjpp-2013-0057","article-title":"The potential contribution of circulating and locally produced leptin to cardiac hypertrophy and failure","volume":"91","author":"Karmazyn","year":"2013","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2017.11.008_bib0260","doi-asserted-by":"crossref","first-page":"H441","DOI":"10.1152\/ajpheart.91537.2007","article-title":"A neutralizing leptin receptor antibody mitigates hypertrophy and hemodynamic dysfunction in the postinfarcted rat heart","volume":"295","author":"Purdham","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"1","key":"10.1016\/j.phrs.2017.11.008_bib0265","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/jcmm.12689","article-title":"Macrophage-mediated cholesterol handling in atherosclerosis","volume":"20","author":"Chistiakov","year":"2016","journal-title":"J. Cell. Mol. Med."},{"issue":"3","key":"10.1016\/j.phrs.2017.11.008_bib0270","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1172\/JCI27883","article-title":"Liver X receptors as integrators of metabolic and inflammatory signaling","volume":"116","author":"Zelcer","year":"2006","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.phrs.2017.11.008_bib0275","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4103\/0975-3583.74267","article-title":"Potential of probiotics in controlling cardiovascular diseases","volume":"1","author":"Saini","year":"2010","journal-title":"J. Cardiovasc. Dis. Res."},{"issue":"6","key":"10.1016\/j.phrs.2017.11.008_bib0280","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.3892\/ijmm.2013.1524","article-title":"Probiotic-fermented purple sweet potato yogurt activates compensatory IGFIR\/PI3K\/Akt survival pathways and attenuates cardiac apoptosis in the hearts of spontaneously hypertensive rats","volume":"32","author":"Lin","year":"2013","journal-title":"Int. J. Mol. Med."},{"issue":"4","key":"10.1016\/j.phrs.2017.11.008_bib0285","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1161\/HYPERTENSIONAHA.114.03469","article-title":"Effect of probiotics on blood pressure: a systematic review and meta-analysis of randomized, controlled trials","volume":"64","author":"Khalesi","year":"2014","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.phrs.2017.11.008_bib0290","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2174\/15701611113119990003","article-title":"Cardiac oxidative stress and inflammatory cytokines response after myocardial infarction","volume":"13","author":"Neri","year":"2015","journal-title":"Curr. Vasc. Pharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2017.11.008_bib0295","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cardiores.2003.10.011","article-title":"Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury","volume":"61","author":"Vinten-Johansen","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2017.11.008_bib0300","series-title":"Intestinal Redox Biology and Oxidative Stress in Seminars in Cell & Developmental Biology","author":"Circu","year":"2012"},{"issue":"2","key":"10.1016\/j.phrs.2017.11.008_bib0305","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00253-012-4241-7","article-title":"Antioxidant properties of potentially probiotic bacteria: in vitro and in vivo activities","volume":"97","author":"Amaretti","year":"2013","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.phrs.2017.11.008_bib0310","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.3389\/fmicb.2017.01687","article-title":"Moderate-intensity exercise affects gut microbiome composition and influences cardiac function in myocardial infarction mice","volume":"8","author":"Liu","year":"2017","journal-title":"Front. Microbiol."},{"issue":"12","key":"10.1016\/j.phrs.2017.11.008_bib0315","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/01.RES.0000130526.20854.fa","article-title":"Inflammatory cytokines and postmyocardial infarction remodeling","volume":"94","author":"Nian","year":"2004","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.phrs.2017.11.008_bib0320","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/1753465810379009","article-title":"Immunomodulatory impact of a synbiotic in T(h)1 and T(h)2 models of infection","volume":"4","author":"Cazzola","year":"2010","journal-title":"Ther Adv Respir Dis"},{"issue":"8","key":"10.1016\/j.phrs.2017.11.008_bib0325","doi-asserted-by":"crossref","first-page":"M423","DOI":"10.1111\/j.1750-3841.2009.01308.x","article-title":"Immunomodulatory properties of fermented soy and dairy milks prepared with lactic acid bacteria","volume":"74","author":"Wagar","year":"2009","journal-title":"J. Food Sci."},{"issue":"11","key":"10.1016\/j.phrs.2017.11.008_bib0330","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1136\/gut.2003.037325","article-title":"Modulation of human dendritic cell phenotype and function by probiotic bacteria","volume":"53","author":"Hart","year":"2004","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.phrs.2017.11.008_bib0335","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/01.fjc.0000250079.46526.38","article-title":"Inhibition of TNF-alpha reduces myocardial injury and proinflammatory pathways following ischemia-reperfusion in the dog","volume":"48","author":"Gu","year":"2006","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2017.11.008_bib0340","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1017\/S0007114512003807","article-title":"Attenuation of post-myocardial infarction depression in rats by n-3 fatty acids or probiotics starting after the onset of reperfusion","volume":"109","author":"Gilbert","year":"2013","journal-title":"Br. J. Nutr."},{"issue":"4","key":"10.1016\/j.phrs.2017.11.008_bib0345","doi-asserted-by":"crossref","first-page":"612","DOI":"10.2337\/dc08-1596","article-title":"Plasma leptin levels and incidence of heart failure: cardiovascular disease, and total mortality in elderly individuals","volume":"32","author":"Lieb","year":"2009","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.phrs.2017.11.008_bib0350","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0014-2999(00)00483-0","article-title":"Taurine attenuates hypertrophy induced by angiotensin II in cultured neonatal rat cardiac myocytes","volume":"403","author":"Azuma","year":"2000","journal-title":"Eur. J. Pharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.phrs.2017.11.008_bib0355","article-title":"Abstract P255: gut microbiota diversity and specific microbial genera associate with cardiovascular disease risk: findings from the bogalusa heart study","volume":"133","author":"Kelly","year":"2016","journal-title":"Circulation"},{"issue":"Suppl. 1","key":"10.1016\/j.phrs.2017.11.008_bib0360","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1073\/pnas.1011383107","article-title":"Human oral, gut, and plaque microbiota in patients with atherosclerosis","volume":"108","author":"Koren","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2017.11.008_bib0365","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/ncomms2266","article-title":"Symptomatic atherosclerosis is associated with an altered gut metagenome","volume":"3","author":"Karlsson","year":"2012","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.phrs.2017.11.008_bib0370","doi-asserted-by":"crossref","first-page":"e105221","DOI":"10.1371\/journal.pone.0105221","article-title":"Elevated levels of circulating DNA in cardiovascular disease patients: metagenomic profiling of microbiome in the circulation","volume":"9","author":"Dinakaran","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.phrs.2017.11.008_bib0375","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1388-9842(03)00104-1","article-title":"Invasive assessment of bacterial endotoxin and inflammatory cytokines in patients with acute heart failure","volume":"5","author":"Peschel","year":"2003","journal-title":"Eur. J. Heart Fail."},{"issue":"1","key":"10.1016\/j.phrs.2017.11.008_bib0380","doi-asserted-by":"crossref","first-page":"e54461","DOI":"10.1371\/journal.pone.0054461","article-title":"Blood microbiota dysbiosis is associated with the onset of cardiovascular events in a large general population: the D. E. S. I. R. study","volume":"8","author":"Amar","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2017.11.008_bib0385","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/msb4100190","article-title":"Probiotic modulation of symbiotic gut microbial-host metabolic interactions in a humanized microbiome mouse model","volume":"4","author":"Martin","year":"2008","journal-title":"Mol. Syst. Biol."},{"issue":"2","key":"10.1016\/j.phrs.2017.11.008_bib0390","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cardfail.2014.11.006","article-title":"Intestinal microbiota-dependent phosphatidylcholine metabolites: diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure","volume":"21","author":"Tang","year":"2015","journal-title":"J. Card. Fail."},{"issue":"12","key":"10.1016\/j.phrs.2017.11.008_bib0395","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.cardfail.2015.09.017","article-title":"Intersections between microbiome and heart failure: revisiting the gut hypothesis","volume":"21","author":"Nagatomo","year":"2015","journal-title":"J Card Fail"},{"issue":"7","key":"10.1016\/j.phrs.2017.11.008_bib0400","doi-asserted-by":"crossref","first-page":"e0180717","DOI":"10.1371\/journal.pone.0180717","article-title":"The changes of gut microbiota after acute myocardial infarction in rats","volume":"12","author":"Wu","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.phrs.2017.11.008_bib0405","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ejheart.2003.12.004","article-title":"Selective intestinal decontamination in advanced chronic heart failure: a pilot trial","volume":"6","author":"Conraads","year":"2004","journal-title":"Eur. J. Heart Fail."},{"issue":"6","key":"10.1016\/j.phrs.2017.11.008_bib0410","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/ajcn\/76.6.1249","article-title":"Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers","volume":"76","author":"Naruszewicz","year":"2002","journal-title":"Am. J. Clin. Nutr."},{"issue":"12","key":"10.1016\/j.phrs.2017.11.008_bib0415","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1017\/S0007114511005137","article-title":"Combination of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 reduces post-myocardial infarction depression symptoms and restores intestinal permeability in a rat model","volume":"107","author":"Arseneault-Breard","year":"2012","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.phrs.2017.11.008_bib0420","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ijcard.2014.11.034","article-title":"Probiotic therapy with Saccharomyces boulardii for heart failure patients: a randomized, double-blind, placebo-controlled pilot trial","volume":"179","author":"Costanza","year":"2015","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"10.1016\/j.phrs.2017.11.008_bib0425","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3920\/BM2016.0119","article-title":"Bifidobacterium animalis subsp: lactis 420 mitigates the pathological impact of myocardial infarction in the mouse","volume":"8","author":"Danilo","year":"2017","journal-title":"Benef Microbes"},{"issue":"7","key":"10.1016\/j.phrs.2017.11.008_bib0430","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1093\/ndt\/gfp007","article-title":"Oral charcoal adsorbent (AST-120) prevents progression of cardiac damage in chronic kidney disease through suppression of oxidative stress","volume":"24","author":"Fujii","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"issue":"2","key":"10.1016\/j.phrs.2017.11.008_bib0435","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nrmicro.2015.23","article-title":"Microbiome Drugs for your bugs","volume":"14","author":"Nunes-Alves","year":"2016","journal-title":"Nat. Rev. Microbiol."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661817312896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661817312896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T20:48:51Z","timestamp":1570308531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661817312896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":87,"alternative-id":["S1043661817312896"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2017.11.008","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myocardial infarction and gut microbiota: An incidental connection","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2017.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}